市場調査レポート
商品コード
1549984
小動物イメージングの世界市場:製品 (光学イメージング・核イメージング・試薬)・用途・地域別の予測 (~2032年)Global Small Animal Imaging Market Research Report Information by Product Optical Imaging, Nuclear Imaging, Reagent, by Application, by Region - Forecast to 2032 |
小動物イメージングの世界市場:製品 (光学イメージング・核イメージング・試薬)・用途・地域別の予測 (~2032年) |
出版日: 2024年08月28日
発行: Market Research Future
ページ情報: 英文 126 Pages
納期: 即納可能
|
小動物イメージングの市場規模は、2022年の11億2,000万米ドル、2023年の11億9,000万米ドルから、予測期間中は6.87%のCAGRで推移し、2032年には23億2,000万米ドルの規模に成長すると予測されています。
製薬業界のR&D費の増加や小動物研究に対する意識の高まりが市場拡大の原動力となっています。
さまざまな方面から小動物研究に対する認識が高まっていることが小動物イメージング産業の成長に大きな影響を与えています。小動物モデルが前臨床研究において果たす重要な役割を認識するステークホルダーが増え、小動物モデルでより精密かつ広範な研究を可能にする高度なイメージング技術への需要が高まっています。
さらに、研究者たちは、病気の原因の解明、治療介入の評価、臨床転帰の予測における小動物イメージングの有用性を認識しており、これが新しいイメージング手法の採用を促進しています。資金提供機関、政府、規制当局が小動物研究を支援する必要性をより強く認識するようになり、投資が拡大し、規制環境が整ってきたことも、この産業を後押ししています。
地域別展望
北米市場が2022年にもっとも高いシェアを占めました。その原因は、北米におけるペットの慢性疾患有病率の上昇、医薬品やバイオテクノロジーのR&D活動の活発化です。
欧州市場はシェアが2番目に高く、製薬・バイオテクノロジー業界における前臨床イメージング需要の高まり、分子イメージングのR&Dへの政府助成金の増加、同地域の大手イメージング機器メーカーの存在感の強さなどがその主な要因です。
アジア太平洋地域は2023年から2032年にかけて大幅に増加すると予想されています。これは、同地域の医療支出の増加、創薬開発における前臨床研究需要の増加、MRI、CT、PET、SPECTなどのイメージングモダリティの技術進歩によるものです。
当レポートでは、世界の小動物イメージングの市場を調査し、市場の定義と概要、市場成長への各種影響因子の分析、市場規模の推移・予測、各種区分・地域別の内訳、競合環境、主要企業のプロファイルなどをまとめています。
Global Small Animal Imaging Market Research Report Information by Product Optical Imaging (Photoacoustic Tomography and Optical Coherence Tomography), Nuclear Imaging (Micro PET System, Micro SPECT System, Micro MRI System, Micro CT System, and Others), Reagent (Optical Image Reagent, Contrast Agent, Pet Tracers, and SPECT Probe), by Application (Monitoring Drug Treatment Programme, Bio Distribution Studies, Cancer Cell Detection, Biomarkers, and Longitudinal Studies), by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast to 2032
In 2022, the Small Animal Imaging Market is expected to be worth USD 1.12 billion. During the projected period (2023-2032), the small animal imaging market is predicted to increase at a compound annual growth rate (CAGR) of 6.87%, from USD 1.19 billion in 2023 to USD 2.32 billion in 2032. The pharmaceutical industry's increased expenditure in R&D, as well as expanding awareness of small animal research, are driving market expansion.
The increasing awareness of small animal research on a variety of fronts has a substantial impact on the growth of the small animal imaging industry. Initially, demand for sophisticated imaging technologies capable of enabling more precise and extensive studies in small animal models is increasing as more stakeholders recognize the critical role that these models play in preclinical research.
Furthermore, researchers recognize the usefulness of small animal imaging in explaining disease causes, evaluating therapeutic interventions, and predicting clinical outcomes, which is driving the adoption of novel imaging modalities. Furthermore, the industry is being boosted by growing investment and favorable regulatory settings as funding agencies, governments, and regulatory authorities become more conscious of the need of supporting small animal research.
Market segmentation insights
The Small Animal Imaging Market is segmented by product into imaging modality and reagent. Imaging modality is further subdivided into optical imaging and nuclear imaging. Imaging studies are organized into three basic categories: computed tomography (CT), magnetic resonance imaging (MRI), and ultrasonography. Additionally, optical imaging is classified into two types: photoacoustic tomography and optical coherence tomography. Nuclear imaging is further classified into five categories: micro-PET systems, micro SPECT systems, micro MRI systems, micro CT systems, and others.
The Small Animal Imaging Market is segmented by application, which includes medication treatment program surveillance, bio distribution studies, cancer cell detection, biomarkers, and long-term research.
Regional Perspectives
In 2022, the North American small animal imaging market had the highest market share. The cause for this is the rising prevalence of chronic diseases in pets in North America, as well as increased research and development activities in medicines and biotechnology.
The second-largest market share in the European small animal imaging market is due to rising demand for preclinical imaging in the pharmaceutical and biotechnology industries, increased government funding for molecular imaging research and development, and the region's strong presence of leading imaging equipment manufacturers.
The Asia-Pacific small animal imaging market is expected to increase significantly between 2023 and 2032. This is due to the region's rising healthcare spending, increased demand for preclinical research in drug discovery and development, and technological advances in imaging modalities such as MRI, CT, PET, and SPECT.
The key companies in the Small Animal Imaging Market include Bruker (US), Analytik Jena GmbH+Co. KG (Germany), Aspect Imaging Ltd (US), MR Solutions (UK), FUJIFILM Holdings Corporation (Japan), MILabs B.V. (Netherlands), Trifoil Imaging (US), Mediso Ltd (Hungary), LI-COR, Inc (US), and Heska Corporation (US).